{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:14:11Z","timestamp":1770822851628,"version":"3.50.1"},"reference-count":23,"publisher":"e-Century Publishing Corporation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/exfn1219","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T23:56:06Z","timestamp":1751241366000},"page":"4315-4322","source":"Crossref","is-referenced-by-count":1,"title":["Nonlinear relationship between TyG index and the risk of non-alcoholic fatty liver disease in Chinese population: a cross-sectional study"],"prefix":"10.62347","volume":"17","author":[{"given":"Tuo","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M and Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med 2018; 24: 908-922.","journal-title":"Nat Med"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Byrne CD and Targher G. NAFLD: a multisystem disease. J Hepatol 2015; 62 Suppl: S47-64.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M and Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65: 1038-1048.","journal-title":"Metabolism"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"EE","year":"2021","unstructured":"Powell EE, Wong VW and Rinella M. Non-alcoholic fatty liver disease. Lancet 2021; 397: 2212-2224.","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, Cohen DE, Horton JD, Pressman GS and Toth PP. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association. Arterioscler Thromb Vasc Biol 2022; 42: e168-e185.","DOI":"10.1161\/ATV.0000000000000153"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"100676","DOI":"10.1016\/j.ajpc.2024.100676","article-title":"Associations between insulin resistance indices and subclinical atherosclerosis: a contemporary review","volume":"18","author":"Scott","year":"2024","unstructured":"Scott DA, Ponir C, Shapiro MD and Chevli PA. Associations between insulin resistance indices and subclinical atherosclerosis: a contemporary review. Am J Prev Cardiol 2024; 18: 100676.","journal-title":"Am J Prev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","article-title":"Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease","volume":"23","author":"Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, Lip GYH, Del Ben M and Baratta F. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol 2024; 23: 175.","journal-title":"Cardiovasc Diabetol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"862919","DOI":"10.3389\/fendo.2022.862919","article-title":"Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a chinese population: a prospective cohort study","volume":"13","author":"Li","year":"2022","unstructured":"Li X, Sun M, Yang Y, Yao N, Yan S, Wang L, Hu W, Guo R, Wang Y and Li B. Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a chinese population: a prospective cohort study. Front Endocrinol (Lausanne) 2022; 13: 862919.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1098492","DOI":"10.3389\/fendo.2022.1098492","article-title":"Association between triglyceride glucose index and risk of cancer: a meta-analysis","volume":"13","author":"Wang","year":"2022","unstructured":"Wang H, Yan F, Cui Y, Chen F, Wang G and Cui W. Association between triglyceride glucose index and risk of cancer: a meta-analysis. Front Endocrinol (Lausanne) 2022; 13: 1098492.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","article-title":"The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults","volume":"19","author":"Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, Li X, Zhu W, Wu J, Xu N and Zhang Q. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis 2020; 19: 218.","journal-title":"Lipids Health Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12890-024-03166-8","article-title":"Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients","volume":"24","author":"Cai","year":"2024","unstructured":"Cai Y, Chen J, Deng X, Wang B, Huang J and Lian N. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients. BMC Pulm Med 2024; 24: 359.","journal-title":"BMC Pulm Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","article-title":"Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, Dai Z, Yin X, Liu R, Li Y and Zhu C. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol 2024; 23: 232.","journal-title":"Cardiovasc Diabetol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/jch.14305","article-title":"The association of triglyceride and glucose index, and triglyceride to high-density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: a large cross-sectional population study","volume":"23","author":"Zhang","year":"2021","unstructured":"Zhang F, Zhang Y, Guo Z, Yang H, Ren M, Xing X and Cong H. The association of triglyceride and glucose index, and triglyceride to high-density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: a large cross-sectional population study. J Clin Hypertens (Greenwich) 2021; 23: 1405-1412.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Yu R, Xie W, Peng H, Lu L, Yin S, Xu S, Hu Z and Peng XE. Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study. BMJ Open 2023; 13: e075413.","DOI":"10.1136\/bmjopen-2023-075413"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40001-024-01736-4","article-title":"Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study","volume":"29","author":"Xie","year":"2024","unstructured":"Xie F, Yu Z, Xiong Y, Wu Z and Wu Y. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study. Eur J Med Res 2024; 29: 145.","journal-title":"Eur J Med Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12933-023-02058-1","article-title":"Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study","volume":"22","author":"Wu","year":"2023","unstructured":"Wu K, Zheng H, Wu W, Chen G, Cai Z, Cai Z, Lan Y, Wu D, Wu S and Chen Y. Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study. Cardiovasc Diabetol 2023; 22: 332.","journal-title":"Cardiovasc Diabetol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M and Steffen HM. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol 2021; 110: 921-937.","journal-title":"Clin Res Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s13300-020-00893-z","article-title":"Establishment of a risk prediction model for non-alcoholic fatty liver disease in type 2 diabetes","volume":"11","author":"Zhang","year":"2020","unstructured":"Zhang Y, Shi R, Yu L, Ji L, Li M and Hu F. Establishment of a risk prediction model for non-alcoholic fatty liver disease in type 2 diabetes. Diabetes Ther 2020; 11: 2057-2073.","journal-title":"Diabetes Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","volume":"78","author":"Nabi","year":"2023","unstructured":"Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K and Serfaty L. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology 2023; 78: 272-283.","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1281839","DOI":"10.3389\/fendo.2023.1281839","article-title":"A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD","volume":"14","author":"Dong","year":"2023","unstructured":"Dong W, Gong Y, Zhao J, Wang Y, Li B and Yang Y. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD. Front Endocrinol (Lausanne) 2023; 14: 1281839.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"795421","DOI":"10.3389\/fmed.2021.795421","article-title":"Sex-specific differences in the association between race\/ethnicity and NAFLD among US population","volume":"8","author":"Shaheen","year":"2021","unstructured":"Shaheen M, Schrode KM, Pan D, Kermah D, Puri V, Zarrinpar A, Elisha D, Najjar SM and Friedman TC. Sex-specific differences in the association between race\/ethnicity and NAFLD among US population. Front Med (Lausanne) 2021; 8: 795421.","journal-title":"Front Med (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF and Suzuki A. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 2019; 70: 1457-1469.","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","article-title":"Hypertension and NAFLD risk: insights from the NHANES 2017-2018 and mendelian randomization analyses","volume":"137","author":"Yuan","year":"2024","unstructured":"Yuan M, He J, Hu X, Yao L, Chen P, Wang Z, Liu P, Xiong Z, Jiang Y and Li L. Hypertension and NAFLD risk: insights from the NHANES 2017-2018 and mendelian randomization analyses. Chin Med J (Engl) 2024; 137: 457-464.","journal-title":"Chin Med J (Engl)"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/6\/ajtr0162361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:26Z","timestamp":1766023046000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/6\/ajtr0162361.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/exfn1219","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}